Emergency authorisation has been sought for the use of Pfizer and Oxford-AstraZeneca’s coronavirus vaccines in India, following the lead of the UK and Russia.
- India has reported the second-highest number of coronavirus cases in the world
- The chief executive of one of the world’s largest vaccine producers said approval would “save countless lives”
- Experts say distribution of Pfizer’s vaccine may be difficult in India because it needs to be kept below -70 degrees Celsius
The Serum Institute…